MediPress Health-Limited Partnership, is a research and development life science partnership and venture capital firm specializing in seed/startups investments. The firm seeks to invest in medical research and development companies. Its portfolio companies engage in the treatment of cancer with proton radiation therapy; and the development of non-surgical vaginal solutions for women with various pelvic floor disorders. The firm seeks to take board positions in its portfolio companies. MediPress Health-Limited Partnership was incorporated in 2021 and is based in Ramat Gan, Israel.
Metrics to compare | MPRSp | Sector Sector - Average of metrics from a broad group of related Financial sector companies | Relationship RelationshipMPRSpPeersSector | |
---|---|---|---|---|
P/E Ratio | 0.0x | −2.6x | 9.5x | |
PEG Ratio | 0.00 | 0.02 | 0.03 | |
Price/Book | 0.0x | 0.7x | 1.0x | |
Price / LTM Sales | 0.0x | 2.3x | 2.8x | |
Upside (Analyst Target) | 0.0% | 16.1% | 13.3% | |
Fair Value Upside | Unlock | 13.4% | 1.6% | Unlock |